Audentes Therapeutics - 48 Year Dividend History | BOLD
Historical dividend payout and yield for Audentes Therapeutics (BOLD) since 1971. The current TTM dividend payout for Audentes Therapeutics (BOLD) as of November 20, 2019 is $0.00. The current dividend yield for Audentes Therapeutics as of November 20, 2019 is 0.00%.
||Medical - Biomedical and Genetics
Audentes Therapeutics, Inc. is a biotechnology company which focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases. The company's product pipeline consists of AT132 for the treatment of X-linked myotubular myopathy; AT342 for the treatment of crigler-najjar syndrome type 1; AT307 for the treatment of the CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia and AT982 for the treatment of pompe disease, which are in pre-clinical trial stage. Audentes Therapeutics, Inc. is based in San Francisco, California.